Randomized, Controlled, Phase 3 Trials of Carteolol/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension

OPC-1085EL is superior to latanoprost or carteolol alone in terms of lowering IOP, and was well tolerated.